Loading…

60P Sacituzumab govitecan (SG) + pembrolizumab (pembro) in first-line (1L) metastatic non-small cell lung cancer (mNSCLC): Efficacy results by histology from the EVOKE-02 study

Saved in:

Bibliographic Details
Published in:	ESMO open 2024-03, Vol.9, p.102639, Article 102639
Main Authors:	Cappuzzo, F., Patel, J., Cho, B.C., Dols, M. Cobo, Cabanillas, R.M. Reyes, Baz, D. Vicente, Pradera, J. Fuentes, Neal, J., Garon, E.B., Mekan, S., Safavi, F., Fernando, N., Chisamore, M., Reck, M.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!